COVID-19 GUIDANCE
Risk Communication and Community Engagement Guidance on COVID-19 Vaccines for Marginalized Population
By RCCE Collective Service including USAID-funded READY Initiative, UNHCR, UNICEF and IOM with input from the GHC COVID-19 Task Team, September 2021.
Read more >>
Considerations for quarantine of contacts of COVID-19 cases: interim guidance. WHO, June 2021. |
Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed. WHO, July 21. |
WHO Living Guidance - Therapeutics and COVID-19. WHO, September 2021. |
Considerations for implementing and adjusting public health and social measures in the context of COVID-19. WHO, June 2021. |
Guidance for Surveillance of SARS-CoV-2 Variants. WHO, August 2021. |
COVID-19 case management capacities: diagnostics, therapeutics, vaccine readiness, and other health products – facility assessment tool. WHO, July 2021. |
Critical preparedness, readiness and response actions for COVID-19. WHO, May 2021. |
Guidance note and checklist for tackling gender-related barriers to equitable COVID-19 vaccine deployment. WHO, March 2017. |
Epi-Win slide set No. 66 on COVID-19 booster doses. WHO, September 2021. |
COVID-19 immunization in refugees and migrants: principles and key considerations: interim guidance. WHO, August 2021. |
Considerations for COVID-19 surveillance for vulnerable populations. WHO, September 2021. |
COVID-19 VACCINE INTRODUCTION TOOLKIT
Provides guidance and tools for partners to prepare for and implement COVID-19 vaccination. Recent useful guidance includes:
COVID-19 vaccine introduction readiness assessment tool – WHO, released 21 September 2021.
COVAX no-fault compensation program for AMC eligible economies – WHO, released 5 July 2021.
WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply –WHO, released 16 July 2021.
Guidance on utilization of COVID-19 vaccines before the date of expiry – WHO, released 18 July 2021.
How to manage COVID-19 vaccines without VVM at vaccination service points – WHO, released 31 August 2021.
Janssen Ad26.COV2-S [recombinant], COVID-19 vaccine – WHO, released 19 August 2021.
Job aid: How to manage storage and distribution of COVID-19 Vaccine Janssen delivered at -20°C and +2 to +8°C temperatures – WHO, released 19 August 2021.
COVID-19 Vaccine Moderna (mRNA-1273) – WHO, released 24 August 2021.
COVID-19 vaccine post-introduction evaluation (cPIE) – WHO, released 25 August 2021.
SAGE - Product specific documentation
See here for the Strategic Advisory Group of Experts on Immunization recommendations for use of different vaccines.
IASC RESOURCES
Low Capacity and Humanitarian Settings
Interim Guidance on Public Health and Social Measures for COVID-19 Preparedness and Response Operations in Low Capacity and Humanitarian Settings. Released 6 May 2020, available here.
Key messages to fast-track health and aid workers and supplies
Key messages to fast-track health and aid workers and supplies at borders and in countries. Communication content to support collective advocacy. Released 7 May 2020, available here.
Keep yourself up to date
WHO RCCE Collective Service, please sign-up for updates here
WHO COVID-19 vaccine newsletter, please sign-up for updates here
WHO COVID-19 digital content newsletter, please sign-up for updates here
WHO Infodemic Management newsletter, please sign-up for updates here
COVID-19 Strategic Preparedness and Response Plan, please read here the Weekly Operational Update.
COVID-19 TASK TEAM
The GHC COVID-19 Task Team established a vaccine working group and is supporting two workstreams: first to monitor and track information on vaccination roll-out in humanitarian settings; and second to ensure shared learning and development of key messages.
